November 5, 2015/Neurosciences

Be Vigilant for Signs of Parkinson Disease

Early interventions can improve long-term outcomes

Parkinson-690×380

Below, Anwar Ahmed, MD, a neurologist in Cleveland Clinic’s Center for Neurological Restoration, addresses key factors in the diagnosis of Parkinson disease.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Q: What is most important to keep in mind about diagnosing this common neurological condition?

A: Some of the early signs of Parkinson disease (PD) are often missed or wrongly attributed to aging. It is important to be vigilant about PD’s early signs because the risk of developing PD is five times higher in people older than 65.

Signs and symptoms of early PD include:

  • Bradykinesia. The patient’s spouse may note that the patient is moving more slowly.
  • Smaller handwriting.
  • Muscle rigidity. This may involve the upper extremities.
  • Tremor. This is present in only 60 percent of PD patients, is usually asymmetric and occurs at rest.
  • Depression and anxiety.
  • A reduced sense of smell. This may occur years before other symptoms.
  • Talking, yelling or physical activity during sleep. This may also occur years before other symptoms.
  • Chronic constipation.

Q: How can early diagnosis impact a patient’s care?

A: Early diagnosis allows the patient to begin implementing lifestyle changes, such as an exercise regimen, that may help control PD symptoms and improve the disease’s long-term progression.

Advertisement

We try not to prescribe medication until symptoms interfere with quality of life. For early PD, we start with MAO-B inhibitors, dopamine agonists and other non-levodopa drugs. Levodopa, a dopamine replacement therapy, is a potent drug and should be reserved for more advanced symptoms.

Q: Where should patients be referred?

A: Movement disorders centers have special expertise in PD. However, if such a center isn’t convenient, well-trained local neurologists also can perform evaluations and recommend appropriate treatment.

An expert neurologist can diagnose PD with high accuracy based on a detailed history and good neurological examination. Imaging with dopamine transporter brain SPECT (single-photon emission computerized tomography) can provide slightly greater accuracy.

Advertisement

Patients with more advanced PD or with complications from standard treatment should be referred to a movement disorders center. There, they can access the latest clinical trials as well as experts in the surgical management of PD.

To refer a patient to the Center for Neurological Restoration, call 855.REFER.123.

Related Articles

sleepless woman looking at clock
Sleep Apnea and Insomnia Are Highly Prevalent and Linked to Disease Worsening in Neuropsychiatric Disorders

Large cohort study suggests need for routine sleep screening as part of neurological care

neuron affected by neuromyelitis optica
Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World Study

Early experience with the agents confirms findings from clinical trials

syringe being prepared for injection
April 15, 2024/Neurosciences/Podcast
Balancing Benefits and Pitfalls of Neurotoxin Injections (Podcast)

Determining the right dose and injecting in the right muscle can be challenging

schematic view of brain connections during an epileptic seizure
April 5, 2024/Neurosciences/Epilepsy
New Insights on the Dynamics of Interictal-to-Ictal Transitions in Epilepsy

Study combines intracranial electrophysiology and SPECT to elucidate the role of hypoperfusion

inflammation on a brain scan with a podcast button overlay
April 2, 2024/Neurosciences/Podcast
Diagnosis and Management of Cerebral Amyloid Angiopathy-Related Inflammation (Podcast)

New research sheds light on a potentially devastating condition that is reversible when properly managed

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

Ad